<?xml version="1.0" encoding="ISO-8859-1" ?><rss version="2.0"><channel><title>HTA Programme - New Projects and Publications</title><description>HTA Programme - New Projects and Publications</description><link>http://www.hta.ac.uk/</link><docs>http://blogs.law.harvard.edu/tech/rss</docs><image><url>http://www.hta.ac.uk/images/logos/HTABannerlogo.gif</url><title>HTA Programme - New Projects and Publications</title><link>http://www.hta.ac.uk/</link></image><item><title>Project: The measurement of patients' expectations for health care</title><description>Chief Investigator: Professor Ann Bowling, Professor of Health Services Research, Primary Care and Population Studies, University College London&lt;br /&gt;Research Type: Methodology&lt;br /&gt;ICD Chapters: Health status/service factors&lt;br /&gt;Key Areas: &lt;br /&gt;Research Type: Methodology&lt;br /&gt;Expected publication date: Early 2011&lt;br /&gt;HTA project ref: 07/58/01</description><link>http://www.hta.ac.uk/project/1685.asp?src=rss</link><guid isPermaLink="true">http://www.hta.ac.uk/project/1685.asp?src=rss</guid></item><item><title>Project: Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: a randomised controlled trial</title><description>Chief Investigator: Dr Nicola Wiles, Senior Lecturer in Epidemiology, Academic Unit of Psychiatry, University of Bristol&lt;br /&gt;Research Type: Primary Research (e.g. trial)&lt;br /&gt;ICD Chapters: Mental illness&lt;br /&gt;Key Areas: Mental health&lt;br /&gt;Interventions: Drug treatment, psychology&lt;br /&gt;ICD Diseases: Depression etc&lt;br /&gt;Research Type: Primary Research (e.g. trial)&lt;br /&gt;Expected publication date: Early 2013&lt;br /&gt;HTA project ref: 06/404/02</description><link>http://www.hta.ac.uk/project/1656.asp?src=rss</link><guid isPermaLink="true">http://www.hta.ac.uk/project/1656.asp?src=rss</guid></item><item><title>Publication: Volume 12, number 9 (Loveman). Clinical and cost-effectiveness of models for educating adults with type 2 diabetes mellitus in diabetes self-management</title><description>Chief Investigator: Southampton Health Technology Assessment Centre (SHTAC), University of Southampton&lt;br /&gt;Research Type: HTA Technology Assessment Report&lt;br /&gt;ICD Chapters: Endocrine, nutritional and metabolic diseases&lt;br /&gt;Key Areas: Diabetes&lt;br /&gt;Interventions: Health promotion&lt;br /&gt;ICD Diseases: Diabetes&lt;br /&gt;Research Type: HTA Technology Assessment Report&lt;br /&gt;Publication date: 16/04/2008&lt;br /&gt;HTA project ref: 06/47/01</description><link>http://www.hta.ac.uk/project/1550.asp?src=rss</link><guid isPermaLink="true">http://www.hta.ac.uk/project/1550.asp?src=rss</guid></item><item><title>Publication: Volume 12, number 12 (Hockenhull). Study found that central venous catheters treated with anti-infective agents can be clinically effective and relatively inexpensive; however their effectiveness in comparison to recommended bundles of care is unclear.</title><description>Chief Investigator: Liverpool Reviews &amp; Implementation Group (LRIG), University of Liverpool&lt;br /&gt;Research Type: Secondary Research (e.g. systematic review)&lt;br /&gt;ICD Chapters: Infectious diseases&lt;br /&gt;Key Areas: &lt;br /&gt;Interventions: Aids and appliances, intensive care and phys support&lt;br /&gt;Research Type: Secondary Research (e.g. systematic review)&lt;br /&gt;Publication date: 16/04/2008&lt;br /&gt;HTA project ref: 05/38/01</description><link>http://www.hta.ac.uk/project/1503.asp?src=rss</link><guid isPermaLink="true">http://www.hta.ac.uk/project/1503.asp?src=rss</guid></item><item><title>Publication: Volume 12, number 10 (Raftery). Payment to healthcare professionals for patient recruitment to trials</title><description>Chief Investigator: Professor James Raftery, Director of WIHRD and Professor of HTA, HTA, University of Southampton&lt;br /&gt;Research Type: Secondary/Primary Research&lt;br /&gt;ICD Chapters: Methodology&lt;br /&gt;Key Areas: &lt;br /&gt;Research Type: Secondary/Primary Research&lt;br /&gt;Publication date: 16/04/2008&lt;br /&gt;HTA project ref: 03/66/01</description><link>http://www.hta.ac.uk/project/1439.asp?src=rss</link><guid isPermaLink="true">http://www.hta.ac.uk/project/1439.asp?src=rss</guid></item><item><title>Publication: Volume 12, number 11 (Chen). Clinical effectiveness and cost-effectiveness of cyclooxygenase-2 (COX-2) selective inhibitors (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis or rheumatoid arthritis.</title><description>Chief Investigator: West Midlands Health Technology Assessment Collaboration (WMHTAC), University of Birmingham&lt;br /&gt;Research Type: NICE Technology Assessment Report (TAR)&lt;br /&gt;ICD Chapters: Bone and joint diseases&lt;br /&gt;Key Areas: Improving the patient experience, older people&lt;br /&gt;Interventions: Drug treatment&lt;br /&gt;ICD Diseases: Osteoarthritis&lt;br /&gt;Research Type: NICE Technology Assessment Report (TAR)&lt;br /&gt;Publication date: 16/04/2008&lt;br /&gt;HTA project ref: 03/34/01</description><link>http://www.hta.ac.uk/project/1383.asp?src=rss</link><guid isPermaLink="true">http://www.hta.ac.uk/project/1383.asp?src=rss</guid></item></channel></rss>
